B1 cells: similarities and differences with other B cell subsets - PubMed (original) (raw)
Review
B1 cells: similarities and differences with other B cell subsets
F Martin et al. Curr Opin Immunol. 2001 Apr.
Abstract
Since their discovery, B1 B cells' origins and developmental pathways have eluded characterization. In the past year, focus on B1 B cells has shifted dramatically from developmental to functional aspects of these cells. Most advances have been made in describing the physiological activities of B1 cells, including their migration, activation by antigen and role in both autoimmunity and malignancy.
Similar articles
- CD5 expression in human B-cell populations.
Youinou P, Jamin C, Lydyard PM. Youinou P, et al. Immunol Today. 1999 Jul;20(7):312-6. doi: 10.1016/s0167-5699(99)01476-0. Immunol Today. 1999. PMID: 10379049 Review. - CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes.
Granziero L, Circosta P, Scielzo C, Frisaldi E, Stella S, Geuna M, Giordano S, Ghia P, Caligaris-Cappio F. Granziero L, et al. Blood. 2003 Mar 1;101(5):1962-9. doi: 10.1182/blood-2002-05-1339. Epub 2002 Oct 24. Blood. 2003. PMID: 12406905 - Modulation of IgD and CD20 by ligation of CD5 on tonsillar B cells.
Morikawa K, Torii I, Morikawa S. Morikawa K, et al. Scand J Immunol. 2002 Jan;55(1):44-52. doi: 10.1046/j.1365-3083.2002.00987.x. Scand J Immunol. 2002. PMID: 11841691 - CD5+ B-cell networks.
Kearney JF. Kearney JF. Curr Opin Immunol. 1993 Apr;5(2):223-6. doi: 10.1016/0952-7915(93)90008-g. Curr Opin Immunol. 1993. PMID: 7685172 Review. - Bar Mitzvah for B-1 cells: how will they grow up?
Tarakhovsky A. Tarakhovsky A. J Exp Med. 1997 Mar 17;185(6):981-4. doi: 10.1084/jem.185.6.981. J Exp Med. 1997. PMID: 9091589 Free PMC article. Review. No abstract available.
Cited by
- Human circulating CD24hi marginal zone B cells produce IgM targeting atherogenic antigens and confer protection from vascular disease.
Pattarabanjird T, Nguyen AT, McSkimming C, Dinh HQ, Marshall MA, Ghosheh Y, Gulati R, Durant C, Vallejo J, Saigusa R, Drago F, Guy TV, Premo K, Taylor AM, Paul S, Kundu B, Berr S, Gonen A, Tsimikas S, Miller Y, Pillai S, Ley K, Hedrick CC, McNamara CA. Pattarabanjird T, et al. Nat Cardiovasc Res. 2023 Nov;2(11):1003-1014. doi: 10.1038/s44161-023-00356-1. Epub 2023 Oct 30. Nat Cardiovasc Res. 2023. PMID: 39196097 - New, Old, and Shared Antibody Specificities in Autoimmune Diseases.
Frasca L, Mennella A, Palazzo R. Frasca L, et al. Antibodies (Basel). 2024 Mar 13;13(1):23. doi: 10.3390/antib13010023. Antibodies (Basel). 2024. PMID: 38534212 Free PMC article. - Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents.
Ilyinskii PO, Roy C, Michaud A, Rizzo G, Capela T, Leung SS, Kishimoto TK. Ilyinskii PO, et al. PNAS Nexus. 2023 Nov 14;2(11):pgad394. doi: 10.1093/pnasnexus/pgad394. eCollection 2023 Nov. PNAS Nexus. 2023. PMID: 38024395 Free PMC article. - Autophagy and Its Lineage-Specific Roles in the Hematopoietic System.
Hasan KMM, Haque MA. Hasan KMM, et al. Oxid Med Cell Longev. 2023 May 3;2023:8257217. doi: 10.1155/2023/8257217. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 37180758 Free PMC article. Review. - Broad responses to chemical adducts shape the natural antibody repertoire in early infancy.
Mashiko S, Shihab RR, See SB, Schahadat LGZ, Aguiar TFM, Roy P, Porcheray F, Zorn E. Mashiko S, et al. Sci Adv. 2023 May 12;9(19):eade8872. doi: 10.1126/sciadv.ade8872. Epub 2023 May 12. Sci Adv. 2023. PMID: 37172087 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI 14782/AI/NIAID NIH HHS/United States
- T32 AI007051/AI/NIAID NIH HHS/United States
- AI07051/AI/NIAID NIH HHS/United States
- CA13148/CA/NCI NIH HHS/United States
- R01 AI014782/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous